Adoptive T Cell Therapy in Pediatric Oncology

Adoptive T Cell Therapy is a cancer treatment where immune cells, specifically T cells, are taken from a patient, modified or enhanced in the lab to better fight cancer, and then infused back into the patient. In pediatric oncology, this approach targets cancers like leukemia. By boosting the T cells’ ability to recognize and attack cancer cells, this therapy aims to improve survival rates and minimize damage to healthy cells, offering hope for children with difficult-to-treat cancers. It represents a personalized approach to cancer treatment, empowering the body’s immune system to combat the disease.